MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 168 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $220,000 | 0.0% | 7,222 | -14.8% | 0.00% | 0.0% |
| Q1 2022 | $220,000 | +8.9% | 8,476 | -41.4% | 0.00% | 0.0% |
| Q4 2017 | $202,000 | +75.7% | 14,456 | +145.9% | 0.00% | 0.0% |
| Q2 2016 | $115,000 | +7.5% | 5,880 | +13.7% | 0.00% | 0.0% |
| Q1 2016 | $107,000 | +33.8% | 5,172 | +33.2% | 0.00% | 0.0% |
| Q4 2015 | $80,000 | -9.1% | 3,882 | -24.3% | 0.00% | 0.0% |
| Q3 2015 | $88,000 | +193.3% | 5,129 | +218.0% | 0.00% | – |
| Q2 2015 | $30,000 | +25.0% | 1,613 | +28.0% | 0.00% | – |
| Q1 2015 | $24,000 | +20.0% | 1,260 | +2.0% | 0.00% | – |
| Q4 2014 | $20,000 | -23.1% | 1,235 | -17.5% | 0.00% | – |
| Q3 2014 | $26,000 | -18.8% | 1,497 | -2.8% | 0.00% | – |
| Q2 2014 | $32,000 | -5.9% | 1,540 | 0.0% | 0.00% | – |
| Q1 2014 | $34,000 | -17.1% | 1,540 | -0.6% | 0.00% | – |
| Q4 2013 | $41,000 | -67.5% | 1,550 | -71.0% | 0.00% | -100.0% |
| Q3 2013 | $126,000 | +106.6% | 5,336 | +89.2% | 0.00% | 0.0% |
| Q2 2013 | $61,000 | – | 2,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |